UBS/CALL/MODERNA/120.001/0.1/20.09.24 Stock

Warrant

OMRN8U

CH1310060863

Market Closed - Swiss Exchange 11:20:00 2024-07-02 am EDT
0.92 CHF -10.68% Intraday chart for UBS/CALL/MODERNA/120.001/0.1/20.09.24
Current month-20.69%
1 month-71.07%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-02 0.92 -10.68%
24-07-01 1.03 -11.21%
24-06-28 1.16 -7.20%
24-06-27 1.25 -30.94%

Delayed Quote Swiss Exchange

Last update July 02, 2024 at 11:20 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
Issuer UBS
OMRN8U
ISINCH1310060863
Date issued 2023-12-27
Strike 120 $
Maturity 2024-09-20 (76 Days)
Parity 10 : 1
Emission price 1.03 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 4.76 CHF
Lowest since issue 0.44 CHF
Spread 0.06 CHF
Spread %6.19%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
118.3 USD
Average target price
145.9 USD
Spread / Average Target
+23.27%
Consensus
  1. Stock Market
  2. Warrants
  3. OMRN8U Warrant